No posts published in this language yet
Once posts are published, you’ll see them here.
top of page
Hyogo Medical University-launched venture company
As a venture company spun out of Hyogo College of Medicine, we develop and support new cell therapies and regenerative medicines originating from academia.
MISSION & VISION
MISSION & VISION
mission
We aim to make regenerative medicine more accessible and become a company needed by patients around the world.
vision
We will promote research and development toward the practical application of regenerative medicine products, the first of their kind in Japan and the world, using amniotic mesenchymal stem cells developed at Hyogo College of Medicine.
In addition to amniotic membrane, we will also conduct cell therapy application research using stem cells derived from fetal appendages such as the umbilical cord and umbilical cord blood, as well as peripheral blood stem cells.
We aim to bring various cell therapy seeds from academia to practical use in society, and provide a wide range of support from research and development to clinical application.
Origin of the company name
The company name, CTEX , is an abbreviation of Cell Therapy and Explorer , and the company aims to develop new treatments for intractable diseases through the exploration of cell therapies.
bottom of page